Le Lézard
Classified in: Health
Subjects: TRI, MAT

Historical Trends in Proficiency Testing Results within The Emerald Testtm Inter-Laboratory Comparison Proficiency Test (ILC/PT) Program


Authors: Wes Burk, Emerald Scientific; Dr Kyle Felling, Rapid Analytics LLC; Adam Floyd, Cascade Lab Consulting; Savino Sguera, Digamma Consulting; Dr Jeff Keller, Rapid Analytics LLC

SAN LUIS OBISPO, Calif., Oct. 25, 2023 /PRNewswire/ -- Proficiency Testing (PT) plays a vital role in establishing and maintaining robust analytical testing laboratory programs. As a leader in providing PT offerings to analytical testing laboratories worldwide, Emerald Scientific has recently conducted a comprehensive analysis of historical PT data from The Emerald Testtm Inter-Laboratory Comparison Proficiency Test (ILC/PT) Program . This blinded review encompasses the last 36 months of the program, aiming to uncover emerging trends in analyte quantification and identify areas for improvement in PT efforts.

The findings from this data analysis will be published in a peer-reviewed and open-access article in the MJBiz Cannabis Science Journal1. The article highlights significant and intriguing trends observed in the quantification of individual analytes and explores their impact on PT efforts in the United States. Furthermore, it discusses the implications of these trends for potential enhancements to future PT initiatives.

"Our goal was to provide an accurate understanding of the current state of analytical testing capabilities in the United States and identify areas where PT efforts can be strengthened," said Wes Burk CEO of Emerald Scientific and one of the authors of the study. "By analyzing historical data from our proficiency testing program, we gained valuable insights that can contribute to the continuous improvement of analytical testing practices."

The collaborative effort between Emerald Scientific, Rapid Analytics LLC, Cascade Lab Consulting, Digamma Consulting, and the leadership of Dr Jeff Keller has resulted in a thorough examination of proficiency testing results within The Emerald Testtm ILC/PT. These efforts are an example of how diverse entities within the cannabis space can work together to create evidence-based approaches that significantly advance scientific rigor for the field.

This research serves as a cornerstone for driving advancements in PT methodologies and establishing industry benchmarks. It reflects the commitment of Emerald Scientific and its partners to promote quality and safety testing practices across the cannabis industry.

For more information about The Emerald Testtm ILC/PT Program and access to previous publications, please visit the Historical Data Analysis page on The Emerald Testtm website.

About Emerald Scientific

In addition to offering The Emerald Testtm ILC/PT Program twice per year, Emerald Scientific is a leading provider of proficiency testsPT studies, and supplies for analytical testing laboratories in the cannabis and hemp industries. With a commitment to promoting quality and safety, Emerald Scientific aims to enhance the scientific understanding and analytical capabilities of these industries.

For media inquiries, please contact:
Kind Publishing, Delany Burk, (805) 801-4185

Press Release Contact:
Wes Burk, CEO
Emerald Scientific
805-801-7061
[email protected]

Footnotes

  1. MJBiz Cannabis Science Journal: https://mjbcannsci.com ?

SOURCE Emerald Scientific


These press releases may also interest you

at 08:15
Pulse Biosciences, Inc. ("Pulse" or the "Company"), a company leveraging its novel and proprietary CellFX® Nanosecond Pulsed Field Ablationtm (nsPFAtm) technology, today announced that the Company's Board of Directors has set the record date for the...

at 08:15
Reprieve Cardiovascular, Inc. (?Reprieve'), a development stage company focused on pioneering an intelligent approach to acute decompensated heart failure (ADHF) treatment, today highlighted the publication of TREAT-AHF study results in JACC: Heart...

at 08:11
The International Association of Eating Disorder Professionals (iaedptm) 2024 Symposium marked a significant milestone, reflecting growth and renewed commitment within the field of eating disorder treatment. The event showcased an impressive array of...

at 08:10
Kelonia Therapeutics, Inc., a biotech company revolutionizing in vivo gene delivery, announced preclinical data from its lead in vivo CAR-T cell therapeutic candidate KLN-1010 in multiple myeloma that will be highlighted at two upcoming scientific...

at 08:10
bioAffinity Technologies, Inc. shares recent Company news. CyPath® Lung Sales Ramp Up Month over Month Sales of CyPath® Lung, our noninvasive diagnostic test for the early detection of lung cancer, continue to climb, with April sales up 21% over...

at 08:07
Lindus Health, the "anti-CRO" running radically faster, more reliable clinical trials for life science pioneers, announced the results of a study examining the motivators and deterrents of clinical trial participation among ethnic minorities. The...



News published on and distributed by: